FOLD : Analysis & Opinions

  1. Amicus Fabry Disease Drug Delayed to 2020 (FOLD)

    November 30, 2016
    The launch of Amicus' Galafold drug to treat Fabry disease has been delayed until at least 2020.
  2. Amicus 3Q Loss $47M or 32 Cents a Share (FOLD)

    November 8, 2016
    Amicus Therapeutics stock soared 21% even though the biotech company reported a 3Q loss.
  3. The Market In 5 Minutes: Condoms, Rose, Condoms!

    May 18, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  4. Chardan Analyst: Amicus Therapeutics Could Be Bought For $22.5 ...

    April 12, 2016
    Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) climbed 7 percent in the pre-market hours after a Wall Street analyst ...
Trading Center